Skip to main navigation Skip to search Skip to main content

Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study

  • Joshua Suresh
  • , Marita Zimmermann
  • , Catherine Maiteki
  • , Anne Stahlfeld
  • , Abigail Pratt
  • , Don P. Mathanga
  • , Sarah Staedke
  • , Miriam Laufer
  • , Chris Drakeley
  • , Caitlin Bever
  • , Lauren Cohee
  • Institute for Disease Modeling
  • Uganda Ministry of Health
  • The Feinberg School of Medicine
  • Gates Foundation
  • Kamuzu University of Health Sciences
  • University of Malawi
  • University of Maryland, Baltimore
  • London School of Hygiene and Tropical Medicine

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background
Intermittent preventive treatment (IPT) of school-aged children with antimalarial drugs decreases rates of infection, anaemia, and clinical malaria. Since school-aged children are a major transmission reservoir, we estimated the effect of IPT for this group on Plasmodium falciparum transmission to younger children and adults across three epidemiological settings.

Methods
With the use of an established malaria transmission model, we developed three epidemiological archetypes (Sahelian, Central, and Southern African) and estimated the effect of IPT of school-age children across transmission levels (P falciparum parasite rate in children aged 2–10 years [PfPR2–10]: 5–40%). Long-lasting insecticide-treated nets and clinical case management were always included as baseline interventions. We compared scenarios for three of the most widely studied drug options (dihydroartemisinin–piperaquine, artesunate–amodiaquine, and sulfadoxine–pyrimethamine–amodiaquine) and delivery options (school-based or community-based), estimating clinical cases averted.

Findings
When long-acting drugs were administered frequently (monthly campaigns with dihydroartemisinin–piperaquine), modelled IPT of school-age children averted 70–90% of cases in school-aged children (up to about 2·0 cases per child per year) and 20–60% of cases in younger children and adults (up to about 0·5 cases per person per year), with greater community benefit at lower transmission levels (PfPR2–10 5–10%). Shorter-acting drugs (sulfadoxine–pyrimethamine–amodiaquine in the Sahelian archetype or artesunate–amodiaquine in the Central and Southern archetypes) administered monthly or longer-acting drugs administered once per school term averted 40–60% of cases in school-aged children (up to about 1·3 cases per child per year) and 15–50% of cases in other ages (up to about 0·5 cases per person per year).

Interpretation
Our model suggests that adding IPT of school-age children to current control tools could decrease malaria burden in this group and reduce P falciparum transmission.
Original languageEnglish
Pages (from-to)e2144-e2152
JournalSciencedirect.com
Volume13
Issue number12
DOIs
Publication statusPublished - 12 Nov 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Themes

  • Malaria and Neglected Tropical Diseases

Fingerprint

Dive into the research topics of 'Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study'. Together they form a unique fingerprint.

Cite this